Wednesday, 29 July 2020

Trump administration taps Kodak to make drug ingredients in US instead of relying on China White House trade adviser Peter Navarro on how Kodak is reinventing themselves to manufacture pharmaceutical ingredients.


Trump administration taps Kodak to make drug ingredients in US instead of relying on China



White House trade adviser Peter Navarro on how Kodak is reinventing themselves to manufacture pharmaceutical ingredients.

https://ift.tt/2X7aMJ8